HomeICCC • NASDAQ
add
ImmuCell Corp
Previous close
$6.37
Day range
$6.06 - $6.35
Year range
$3.38 - $7.60
Market cap
54.82M USD
Avg Volume
17.31K
P/E ratio
32.19
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 6.44M | 17.76% |
Operating expense | 2.25M | -14.09% |
Net income | 501.88K | 132.77% |
Net profit margin | 7.79 | 127.83% |
Earnings per share | — | — |
EBITDA | 1.24M | 272.96% |
Effective tax rate | 0.38% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.00M | 352.96% |
Total assets | 46.72M | 11.62% |
Total liabilities | 16.85M | -8.41% |
Total equity | 29.87M | — |
Shares outstanding | 9.05M | — |
Price to book | 1.93 | — |
Return on assets | 3.08% | — |
Return on capital | 3.24% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 501.88K | 132.77% |
Cash from operations | 1.60M | 175.28% |
Cash from investing | -125.93K | -18.53% |
Cash from financing | -76.45K | 31.50% |
Net change in cash | 1.40M | 284.44% |
Free cash flow | 1.67M | 58.99% |
About
Founded
1982
Headquarters
Website
Employees
73
